Sotalol

This classification denotes a cation channel blocker and adrenergic antagonist with the molecular formula C12H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) A6D97U294I, chemically known as methanesulfonanilide, 4-(1-hydroxy-2-(isopropylamino)ethyl)- but more generally known as sotalol, which bears US NIH Compound Identifier 5253. European Medicines Agency schedules Sotalol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10607MIG. The term SOTALOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules sotalol in its Anatomical Therapeutic Chemical (ATC) Classification. SOTALOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule sotalol under HS 29350090 and SITC 51580. As of Q4 2014, SOTALOL remains US FDA's Preferred Term for this commodity. Sotalol bears US NLM identifiers UMLS ID C0037707 and NCI Concept Code C61949. SMILES: S(=O)(=O)(NC1CCC(C(O)CNC(C)C)CC1)C.